Myozyme and Solu-medrol drug interactions - a phase IV clinical study of FDA data


Drug interactions are reported among people who take Myozyme and Solu-medrol. Common interactions include cyanosis among females and body temperature decreased among males.

The phase IV clinical study analyzes what interactions people who take Myozyme and Solu-medrol have. It is created by eHealthMe based on reports of 17 people who take Myozyme and Solu-medrol from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Aug, 16, 2022

17 people who take Myozyme and Solu-medrol together, and have interactions are studied.

What is Myozyme?

Myozyme has active ingredients of alglucosidase alfa. eHealthMe is studying from 2,795 Myozyme users for its effectiveness, alternative drugs and more.

What is Solu-medrol?

Solu-medrol has active ingredients of methylprednisolone sodium succinate. It is often used in multiple sclerosis. eHealthMe is studying from 30,302 Solu-medrol users for its effectiveness, alternative drugs and more.

Number of Myozyme and Solu-medrol reports submitted per year:

Myozyme and Solu-medrol drug interactions.

Common Myozyme and Solu-Medrol drug interactions by gender *:


  1. Cyanosis
  2. Antibody test positive
  3. Blood immunoglobulin a decreased
  4. Blood pressure increased
  5. Cardiac murmur
  6. Cardio-respiratory arrest
  7. Chronic respiratory failure
  8. Disease progression
  9. Heart rate increased
  10. Hyperthermia malignant


  1. Body temperature decreased
  2. Heart rate increased
  3. Drug hypersensitivity
  4. Dyskinesia
  5. Hyperhidrosis
  6. Respiratory rate increased
  7. Rhinorrhoea
  8. Tachycardia
  9. Blood pressure decreased
  10. Bronchopneumonia

Common Myozyme and Solu-Medrol drug interactions by age *:


  1. Heart rate increased
  2. Oxygen saturation decreased
  3. Respiratory rate increased
  4. Antibody test positive
  5. Blood immunoglobulin a decreased
  6. Blood pressure increased
  7. Cardiac murmur
  8. Cardio-respiratory arrest
  9. Chronic respiratory failure
  10. Cyanosis


  1. Cyanosis
  2. Infusion related reaction
  3. Hypersensitivity
  4. Joint swelling
  5. Pallor
  6. Rash macular
  7. Urticaria
  8. Vomiting
  9. Catheter site erythema
  10. Catheter site pruritus













Common conditions people have *:

  1. Hypersensitivity: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Myozyme and Solu-medrol?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Myozyme and Solu-medrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Solu-medrol interactions:

Browse all interactions between Solu-medrol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on alglucosidase alfa and methylprednisolone sodium succinate (the active ingredients of Myozyme and Solu-medrol, respectively), and Myozyme and Solu-medrol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Myozyme and Solu-medrol.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: